{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:42:13Z","timestamp":1773016933502,"version":"3.50.1"},"reference-count":21,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,8,17]]},"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>The COVID-19 pandemic and a consequent nationwide lockdown in India for several weeks had restricted the access to street heroin and treatment for substance abuse. Use of cutting agents to increase the volume or psychoactive effect has been widely practised under such circumstances. Our patient with opioid use disorder chased heroin with an unknown cutting agent to enhance psychoactive effect from the limited quantities of heroin. He suffered from an abrupt onset sedation, weakness, postural imbalance, slurred speech, cognitive dysfunctions and disinhibited behaviour. Symptoms rapidly reversed following abstinence and initiation of buprenorphine\u2013naloxone. Gas chromatography-mass spectrometric analysis of the adulterant revealed high concentrations of benzodiazepines and barbiturates, alongside the usual cutting agents\u2014caffeine and acetaminophen. Abrupt reduction in availability of \u2018street drugs\u2019 in conjunction with poor healthcare access can lead to the use of novel adulterants with potentially serious clinical and public health implications.<\/jats:p>","DOI":"10.1136\/bcr-2021-242239","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T13:10:14Z","timestamp":1629897014000},"page":"e242239","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Serious health threats of novel adulterants of the street heroin: a report from India during the COVID-19 pandemic"],"prefix":"10.1136","volume":"14","author":[{"given":"Tathagata","family":"Mahintamani","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Jain","sequence":"additional","affiliation":[{"name":"Toxicilogy Department, Central Forensic and Science Laboratory, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"2025082708282934000_14.8.e242239.1","unstructured":"United Nations . World drug report 2020, 2021. Available: https:\/\/wdr.unodc.org\/wdr2020\/index.html [Accessed 10 Jan 2021]."},{"key":"2025082708282934000_14.8.e242239.2","unstructured":"United Nations : Office on Drugs and Crime . UNODC world drug report 2020: global drug use rising; while COVID-19 has far reaching impact on global drug markets, 2021. Available: https:\/\/www.unodc.org\/unodc\/press\/releases\/2020\/June\/media-advisory---global-launch-of-the-2020-world-drug-report.html [Accessed 10 Jan 2021]."},{"key":"2025082708282934000_14.8.e242239.3","unstructured":"United Nations : Office on Drugs and Crime . COVID-19 is changing the route of illicit drug flows, says UNODC report, 2021. Available: https:\/\/www.unodc.org\/unodc\/frontpage\/2020 \/May\/covid-19-is-changing-the-route-of-illicit-drug-flows--says-unodc-report.html [Accessed 10 Jan 2021]."},{"key":"2025082708282934000_14.8.e242239.4","unstructured":"Ambekar A , Agrawal A , Rao R . Magnitude of substance use in India. New Delhi: Ministry of Social Justice and Empowerment, Government of India, 2019."},{"key":"2025082708282934000_14.8.e242239.5","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0000216155.52411.6e","article-title":"MRI features of spongiform leukoencephalopathy following heroin inhalation","volume":"67","author":"Chang","year":"2006","journal-title":"Neurology"},{"key":"2025082708282934000_14.8.e242239.6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00062-010-0022-9","article-title":"Toxic leukoencephalopathy after heroin abuse without heroin vapor inhalation: MR imaging and clinical features in three patients","volume":"20","author":"Blasel","year":"2010","journal-title":"Clin Neuroradiol"},{"key":"2025082708282934000_14.8.e242239.7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.047134"},{"key":"2025082708282934000_14.8.e242239.8","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7517-8-3","article-title":"Chasing the dragon - characterizing cases of leukoencephalopathy associated with heroin inhalation in British Columbia","volume":"8","author":"Buxton","year":"2011","journal-title":"Harm Reduct J"},{"key":"2025082708282934000_14.8.e242239.9","first-page":"111","article-title":"[\"Heroin\" leukoencephalopathy]","volume":"126","author":"Wolters","year":"1982","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2025082708282934000_14.8.e242239.10","unstructured":"Kang M , Galuska M , Ghassemzadeh S . Benzodiazepine toxicity, 2021. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482238\/ [Accessed 10 Jan 2021]."},{"key":"2025082708282934000_14.8.e242239.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03330290043027"},{"key":"2025082708282934000_14.8.e242239.12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.forsciint.2015.09.014","article-title":"Qualitative, quantitative and temporal study of cutting agents for cocaine and heroin over 9 years","volume":"257","author":"Bros\u00e9us","year":"2015","journal-title":"Forensic Sci Int"},{"key":"2025082708282934000_14.8.e242239.13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.drugpo.2019.07.025","article-title":"When does the cutting of cocaine and heroin occur? The first large-scale study based on the chemical analysis of cocaine and heroin seizures in Switzerland","volume":"73","author":"Morelato","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2025082708282934000_14.8.e242239.14","first-page":"4461","article-title":"Commentary - Heroin purity and adulteration: an updated snapshot from the Italian Early Warning System","volume":"24","author":"Tittarelli","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025082708282934000_14.8.e242239.15","unstructured":"United Nations : Office on Drugs and Crime . Afghanistan identifies cutting agents for heroin, 2021. Available: https:\/\/www.unodc.org\/unodc\/en\/frontpage\/2009\/June\/afghanistan-identifies-cutting-agents-for-heroin.html [Accessed 10 Jan 2021]."},{"key":"2025082708282934000_14.8.e242239.16","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6643e1"},{"key":"2025082708282934000_14.8.e242239.17","doi-asserted-by":"publisher","DOI":"10.1016\/0379-0738(94)90228-3"},{"key":"2025082708282934000_14.8.e242239.18","unstructured":"Cole C , Jones L , McVeigh J . Cut: a guide to Adulterants, bulking agents and other contaminants found in illicit drugs. Liverpool: John Moores University, 2010."},{"key":"2025082708282934000_14.8.e242239.19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2361","article-title":"Alcohol or benzodiazepine Co-involvement with opioid overdose deaths in the United States, 1999-2017","volume":"3","author":"Tori","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025082708282934000_14.8.e242239.20","unstructured":"Centers for Disease Control and Prevention . Coronavirus disease 2019, 2021. Available: https:\/\/www.cdc.gov\/media\/releases\/2020\/p1218-overdose-deaths-covid-19.html [Accessed 10 Jan 2021]."},{"key":"2025082708282934000_14.8.e242239.21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1973.03220250027010"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-242239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:28:41Z","timestamp":1756308521000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-242239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,25]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1136\/bcr-2021-242239"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-242239","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}